Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5424-08-8

Post Buying Request

5424-08-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5424-08-8 Usage

General Description

2,2-diphenyl-4-(piperidin-1-yl)butanenitrile is a chemical compound with the molecular formula C24H26N2. It is a nitrile derivative that contains a piperidine ring and two phenyl groups. 2,2-diphenyl-4-(piperidin-1-yl)butanenitrile has potential applications in medicinal chemistry and drug development, particularly as a building block for the synthesis of various pharmaceuticals and biologically active molecules. It may also have use as a ligand in coordination chemistry and in organic synthesis. The compound's properties and reactivity make it a valuable tool for chemical research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 5424-08-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,2 and 4 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5424-08:
(6*5)+(5*4)+(4*2)+(3*4)+(2*0)+(1*8)=78
78 % 10 = 8
So 5424-08-8 is a valid CAS Registry Number.

5424-08-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,2-diphenyl-4-piperidin-1-ylbutanenitrile

1.2 Other means of identification

Product number -
Other names 2,2-diphenyl-4-piperidin-1-yl-butyronitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5424-08-8 SDS

5424-08-8Relevant articles and documents

Overcoming chloroquine resistance in malaria: Design, synthesis and structure-activity relationships of novel chemoreversal agents

Boudhar, Aicha,Ng, Xiao Wei,Loh, Chiew Yee,Chia, Wan Ni,Tan, Zhi Ming,Nosten, Francois,Dymock, Brian W.,Tan, Kevin S.W.

, p. 231 - 249 (2016/05/24)

Malaria remains a significant infectious disease with even artemisinin-based therapies now facing resistance in the field. Development of new therapies is urgently needed, either by finding new compounds with unique modes of action, or by reversing resistance towards known drugs with 'chemosensitizers' or 'chemoreversal' agents (CRA). Concerning the latter, we have focused on the resistance mechanisms developed against chloroquine (CQ). We have synthesized a series of compounds related to previously identified CRAs, and found promising novel compounds. These compounds show encouraging results in a coumarin labeled chloroquine uptake assay, exhibiting a dose response in resensitising parasites to the antimalarial effects of chloroquine. Selected compounds show consistent potency across a panel of chloroquine and artemisinin sensitive and resistant parasites, and a wide therapeutic window. This data supports further study of CRAs in the treatment of malaria and, ultimately, their use in chloroquine-based combination therapies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5424-08-8